LDHA and ovarian carcinoma: Bromodomain 4 (BDM4) was shown to be required for ALD1A expression in ovarian cancer cells; in line with this finding, Bromodomain and Extraterminal (BET) inhibitors suppress ALDH activity by abrogating BRD4-mediated ALDH1A expression [218].